It is a company with a futuristic weapon in the fight against diabetes, but it has faced a few hurdles this earnings season. Jim Cramer spoke with the CEO to see if …
source CNBC
It is a company with a futuristic weapon in the fight against diabetes, but it has faced a few hurdles this earnings season. Jim Cramer spoke with the CEO to see if …
source CNBC
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More